Form 4: Elanco EVP Acquires Deferred Stock Units

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 66.042 deferred stock units on October 17, 2025, increasing his beneficial ownership to 7,099.3043 units.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. (ELAN), acquired 66.042 Deferred Stock Units (DSUs).
• The transaction occurred on October 17, 2025.
• Each DSU represents the right to receive one share of company common stock or its cash equivalent.
• The DSUs were valued at $21.42 per unit for this transaction.
• Following this acquisition, Modi beneficially owns a total of 7,099.3043 DSUs.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by a key executive, especially under a 10b5-1 plan, generally indicates management's confidence in the company's long-term prospects, which is a moderately positive signal for investors.

Positives

• An executive acquiring additional deferred stock units can be seen as a positive signal of confidence in the company's future performance.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary acquisition.

Risks

• The value of the deferred stock units is tied to the future performance of Elanco Animal Health Inc.'s common stock, exposing the holder to market fluctuations.

Future Outlook

This Form 4 primarily reports a past transaction and does not contain explicit forward-looking statements or guidance. The acquisition of DSUs by an executive might implicitly suggest confidence in future performance.

Industry Context

This is an insider transaction, which is company-specific. It doesn't directly relate to broader industry trends, though executive compensation structures are common across industries.

Comparison to Industry Standards

• This filing reports a standard executive compensation transaction (acquisition of DSUs). Such plans are common across publicly traded companies as a form of long-term incentive. Specific comparable companies or projects are not relevant here as it's a routine insider transaction.

Stakeholder Impact

• Shareholders: The acquisition by an executive may be viewed as a positive signal of confidence, potentially influencing investor sentiment.

Next Steps

• The deferred stock units will settle in cash or shares following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units by an executive under a pre-arranged plan. While it signals management confidence, it does not provide new fundamental information to warrant a change in investment recommendation. Investors should hold their positions and consider broader company performance and market conditions.

Keywords

Elanco Animal Health, ELAN, Rajeev A. Modi, Deferred Stock Units, DSU, Insider Trading, SEC Form 4, Executive Compensation, Stock Acquisition, Rule 10b5-1